Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
4.890
+0.080 (1.66%)
Dec 5, 2025, 4:00 PM EST - Market closed
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $214.23 million as of December 5, 2025. Its market cap has decreased by -33.08% in one year.
Market Cap
214.23M
Enterprise Value
212.70M
1-Year Change
-33.08%
Ranking
Category
Stock Price
$4.89
Market Cap Chart
Since the IPO on February 9, 2021, Nyxoah's market cap has decreased from $506.14M to $214.23M, a decrease of -57.67%. That is a compound annual growth rate of -16.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 214.23M | -33.07% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | 7.71% |
| Feb 9, 2021 | 506.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |